Therapy for chronic hepatitis B: Nucleoside analogues in adult and pediatric patients

Acta Gastro-Enterologica Belgica

Volumn 61, Issue 2, 1998, Pages 224-227

  Conjeevaram, H S ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Famciclovir; Hepatitis B; Lamivudine; Nucleoside analogue; Therapy

Indexed keywords

FAMCICLOVIR; LAMIVUDINE; NUCLEOSIDE ANALOG;

CONFERENCE PAPER; HEPATITIS B; HUMAN; LIVER CELL CARCINOMA; LONG TERM CARE; MORBIDITY; MORTALITY; TREATMENT INDICATION; TREATMENT PLANNING; VIRUS INFECTION;

2-AMINOPURINE; ADULT; ANTIVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS; FEMALE; HEPATITIS B, CHRONIC; HUMANS; LAMIVUDINE; MALE; NUCLEOSIDES; TREATMENT OUTCOME;

EID: 0031814837     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)

1. MAYNARD J E Hepatitis B : global importance and need for control. Vaccine, 1990, 8 : 18-20.
2. CONJEEVARAM H.S DiBisceglie Management of chronic viral hepatitis in children. J Pediatr Gastroenterol. Nutr., 1995, 20 365-375.
3. NIESTERS H.G.M. New nucleoside analogues for chronic hepatitis B J Hepatology, 1995, 22 (suppl. 1) : 52-56
4. DOONG S L., TSAI C H, SCHINAZI R. F., LIOTIA D.C., CHENG Y.C. Inhibition of the replication of hepatitis B virus in vitro by 2′ 3′-dideoxy-3′-thiacytidine and related analogues Proc Natl Acad Sci. USA, 1991, 88 : 8495-8499
5. SHAW L., MOK S.S, and LOCARNINI S.A Inhibition of hepatitis B virus DNA polymerase by enantiomers of penciclovir triphosphate and metabolic basis for selective inhibition of HBV replication by penciclovir Hepatology, 1996, 24 : 996-1002.
6. MC KENZIE R, FRIED M W., SALLIF R, CONJEEVARAM H.S., DI BISCEGLIE A.M., PARK Y., SAVARESE B. et al. Hepatic failure and lactic acidosis : severe multisystem toxicity from FIAU, an antiviral therapy for chronic hepatitis B. N Engl. J. Med , 1995, 333 1099-1105.
7. PERRY C.M , FAULDS D. Lamivudine. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in the management of HIV infection. Drugs, 1997, 53 : 657-680.
8. DIENSTAG J.L., PERRILLO R.P., SCHIFF E.R., BARTHOLOMEW M., VICARY C., RUBIN M A preliminary trial of Lamivudine for chronic viral hepatitis B infection. N. Engl J. Med., 1995, 333 : 1657-1661
9. NEVENS F, MAIN J., HONKOOP P., TYRRELL D.L., BARBER J , SULLIVAN M.T., FEVERY J et al. Lamivudine therapy for chronic hepatitis B A six-month randomized dose-ranging study. Gastroenterology, 1997, 113 : 1258-1263.
10. LAI C.L., CHING C.K., TUNG A K M., LIE, YOUNG J., HILL A., WONG B C.Y. et al Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers A placebo-controlled trial. Hepatology, 1997, 25 : 241-244.
11. DIENSTAG J.L., SCHIFF E.R., MITCHELL M., GITLIN N., LISSOOS T., CONDREAY L., GARRETT L. et al Extended lamivudine retreatment for chronic hepatitis B. Hepatology, 1996, 24 : 188 A (Abstract).
12. HONKOOP P, DE MAN R A , ZONDERVAN R P.E., SCHALM S.W. Histological improvement in patients with chronic hepatitis B virus infection treated with lamivudine. Liver, 1997, 17 : 103-106.
13. HONKOOP P., DE MAN R.A., HEIJTINK R.A., SCHALM S.W Hepatitis B reactivation after lamivudine Lancet, 1995, 346 : 1156-1157
14. VAN THIEL D.H, FRIEDLANDER L , KANIA R.J., MOLLOY P.J , HASSANEIN T., WAHLSTROM E., FARUKI H. Lamivudine treatment of advanced and decompensated liver disease due to hepatitis B. Hepatogastroenterol., 1997, 44 : 808-812.
15. BAIN VG., KNETEMAN N.M , MA M.M., GUTFREUND K., SHAPIRO J.A , FISCHER K., TIPPLES G. et al Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation. Transplantation, 1996, 62 : 1456-1462
16. GRELLIER L., MUTIMER D., AHMED M., BROWN D., BURROUHS A.K., ROLLES K., MCMASTER P. et al. Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis Lancet, 1996, 348 : 1212-1215
17. BEN-ARI Z., SHMUELI D , MOR E , SHAHARABANI E , BARNATHA N., SHAPIRA Z., TUR-KASPA R Beneficial effect of lamivudine pre- and post-liver transplantation for hepatitis B infection. Transpl Proc , 1997, 29 : 2687-2688.
18. BEN-ARI Z., SHMUELI D., MOR E., SHAPIRA Z., TUR-KASPA R. Beneficial effect of lamivudine in recurrent hepatitis B after liver transplantation. Transplantation, 1997, 63 : 393-396.
19. LING R., MUTIMER D., AHMED M., BOXALL E.H., ELIAS E , DUSHEIKO G M., HARRISON T.J. Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine Hepatology, 1996, 24 : 711-713.
20. TIPPLES G A, MA M.M., FISCHER K.P, BAIN V.G, KNETEMAN N M , TYRRELL D.L. Mutation in HBV RNA-dcpendent DNA polymerase confers resistance to lamivudine in vivo. Hepatology, 1996, 24 : 714-717.
21. BARTHOLOMEW M.M., JANSEN R.W., JEFFERS L J., REDDY K.R , JOHNSON L C., BUNZENDAHL H., CONDREAY L.D. et al. Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet, 1997, 349 : 20-22.
22. HONKOOP P., NIESTERS H.G.M., DE MAN R.A., OSTERHAUS A.D.M.E, SCHALM S.W. Lamivudine resistance in immunocompetent chronic hepatitis B. J Hepatol., 1997, 26 : 1393-1395.
23. TSIQUAYE K.N, SLOMKA M.J., MAUNG M Oral famciclovir against duck hepatitis B virus replication in hepatic an nonhepatic tissues of ducklings infected in ovo. J Med. Virol., 1994, 42 : 306-310.
24. MAIN J., BROWN J.L., HOWELLS C., GALASSINI R., KARAYIANNIS P., GEORGIOU P., ATKINSON G et al. A double-blind, placebocontrolled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B virus infection. J Viral Hepatitis. 1996, 3 : 211-215
25. SINGH N., GAYOWSKI T., WANNSTEDT C.F. WAGENER M.M., MARINO I.R Pretransplant famcilovir as prophylaxis for hepatitis B virus recurrence after liver transplantation. Transplantation, 1997, 63 : 1415-1419.
26. KRUGER M., TILLMANN H.L., TRAUTWEIN C., BODE U., OLDHAFER K., MASCHEK H., BOKER K H.W. et al Famciclovir treatment of hepatitis B virus recurrence after liver transplantation : A pilot study. Liver Transpl. Surg., 1996, 2 : 253-262.
27. COLLEDGE D, LOCARNINI S., SHAW T. Synergistic inhibition of hepadnaviral replication by lamivudine in combination with penciclovir in vitro. Hepatology, 1997, 26 : 216-225.